Fehér, K., Tornai, D., Vitális, Z., Dávida, L., Sipeki, N., Papp, M.: Non-pancreatic hyperlipasemia: a puzzling clinical entity.
World J. Gastroenterol. 30 (19), 2538-2552, 2024.

Tornai, D., Mitchell, M., McClain, C., Dasarathy, S., McCullough, A., Radaeva, S., Kroll-Desrosiers, A., Lee, J., Barton, B., Szabó, G.: A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: a multicenter plasma biomarker analysis.
Hepatol. Commun. 7 (12), 1-13, 2023.

Sciascia, S., Bizzaro, N., Meroni, P., Bogdanos, D., Borghi, M., Bossuyt, X., Grossi, C., Tornai, D., Papp, M., Shoenfeld, Y., Ielo, D., Fritzler, M.: Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value.
Autoimmun. Rev. 22 (7), 1-9, 2023.

Cho, Y., Bukong, T., Tornai, D., Babuta, M., Vlachos, I., Kanata, E., Catalano, D., Szabó, G.: Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcoholic hepatitis.
J. Hepatol. 78 (1), 28-44, 2023.

Walmsley, M., Tornai, D., Cazzagon, N., Leburgue, A., Mrzljak, A., Lenzen, H., Carbone, M., Madaleno, J., Lleo, A., Junge, N., Schramm, C., Bergquist, A.: Patient-reported quality of care in primary sclerosing cholangitis.
Liver Int. 43 (8), 1654-1662, 2023.

Janka, T., Tornai, D., Papp, M., Vitális, Z.: The Value of Neutrophil-to-Lymphocyte Ratio to Identify Bacterial Infection and Predict Short-Term Mortality in Patients with Acutely Decompensated Cirrhosis.
Diagnostics. 13 (18), 1-14, 2023.

Vitális, Z., Balogh, B., Tornai, D., Papp, M.: A máj-cirrhosis akut dekompenzációja.
Orvostovábbk. szle. 29 (3), 57-71, 2022.

Szabó, G., Mitchell, M., McClain, C., Dasarathy, S., Barton, B., McCullough, A., Nagy, L., Kroll-Desrosiers, A., Tornai, D., Min, H., Radaeva, S., Holbein, M., Casey, L., Cuthbert, J.: IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.
Hepatology. 76 (4), 1058-1068, 2022.

Szabó, G., Mitchell, M., McClain, C., Dasarathy, S., Barton, B., McCullough, A., Nagy, L., Kroll-Desrosiers, A., Tornai, D., Min, H., Radaeva, S., Casey, L., Cuthbert, J.: Response from Authors of HEP-21-2131.R1.
Hepatology. 76 (5), E114-E115, 2022.

Tornai, D., Vén, P., Lakatos, P., Papp, M.: Serological biomarkers for management of primary sclerosing cholangitis.
World J. Gastroenterol. 28 (21), 2291-2301, 2022.

Tornai, D., Antal-Szalmás, P., Tornai, T., Papp, M., Tornai, I., Sipeki, N., Janka, T., Balogh, B., Vitális, Z.: Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study.
BMC Gastroenterol. 21 (1), 1-13, 2021.

Tornai, D., Papp, M.: Editorial: serologic antibodies in primary sclerosing cholangitis - a tell-tale sign of compromised gut-liver immunity?.
Aliment. Pharmacol. Ther. 53 (2), 350-351, 2021.

Tornai, D., Vitális, Z., Jónás, A., Janka, T., Földi, I., Tornai, T., Sipeki, N., Csillag, A., Balogh, B., Sümegi, A., Földesi, R., Papp, M., Antal-Szalmás, P.: Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.
Clin. Res. Hepatol. Gastroenterol. 45 (5), 1-12, 2021.

Janka, T., Tornai, T., Borbély, B., Tornai, D., Altorjay, I., Papp, M., Vitális, Z.: Deleterious effect of proton pump inhibitors on the disease course of cirrhosis.
Eur. J. Gastroenterol. Hepatol. 32 (2), 257-264, 2020.

Tornai, D., Szabó, G.: Emerging medical therapies for severe alcoholic hepatitis.
Clin Mol Hepatol. 26 (4), 686-696, 2020.

Csillag, A., Vitális, Z., Tornai, T., Tornai, I., Tornai, D., Balogh, B., Antal-Szalmás, P., Papp, M.: Filamentosus-actin related molecules: are they serologic hallmark of overwhelming damage-associated molecular patterns (DAMPs) in acute decompensation?.
In: "PROCEEDINGS OF THE EFOP-3.6.2- 16-2017-00006 (LIVE LONGER) PROJECT". Ed.: Rakonczay Zoltán, Kiss Lóránd, Szegedi Tudományegyetem, Szeged, 63, 2020. ISBN: 9789633067642

Balogh, B., Vitális, Z., Tornai, T., Tornai, I., Tornai, D., Csillag, A., Antal-Szalmás, P., Papp, M.: Gut barrier failure: a piece in the puzzle of acute-on chronic liver failure syndrome development?.
In: Proceedings of the EFOP-3.6.2-16-2017-00006 (LIVE LONGER) project /Ed. Rakonczay Zoltán, Kiss Lóránd, University of Szeged, Szeged, 62, 2020.

Lowe, P., Cho, Y., Tornai, D., Coban, S., Catalano, D., Szabó, G.: Inhibition of the Inflammasome Signaling Cascade Reduces Alcohol Consumption in Female But Not Male Mice.
Alcohol. Clin. Exp. Res. 44 (2), 567-578, 2020.

Mezei, Z., Tornai, D., Földesi, R., Madar, L., Sümegi, A., Papp, M., Antal-Szalmás, P.: A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation: testing several different ITD sequences and rates, simultaneously.
J. Biotechnol. 303 25-29, 2019.

Tornai, D., Mitchell, M., McClain, C., Dasarathy, S., McCullough, A., Radaeva, S., Kroll-Desrosiers, A., Barton, B., Szabó, G.: A novel composite score of biomarkers and age predicts mortality in severe alcoholic hepatitis patients.
Hepatology. 70 (Suppl.), 835A, 2019.

Saha, B., Tornai, D., Kodys, K., Adejumo, A., Lowe, P., McClain, C., Mitchell, M., McCullough, A., Dasarathy, S., Kroll-Desrosiers, A., Barton, B., Radaeva, S., Szabó, G.: Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis.
Hepatology. 70 (4), 1134-1149, 2019.

Tornai, D., Furi, I., Shen, Z., Sigalov, A., Coban, S., Szabó, G.: Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice.
Hepatol. Commun. 3 (1), 99-115, 2019.

Dinya, T., Tornai, T., Vitális, Z., Tornai, I., Balogh, B., Tornai, D., Antal-Szalmás, P., Sümegi, A., Andrikovics, H., Bors, A., Tordai, A., Papp, M.: Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis.
Liver Int. 38 (7), 1242-1252, 2018.

Tornai, T., Tornai, D., Sipeki, N., Tornai, I., Alsulaimani, R., Fechner, K., Roggenbuck, D., Norman, G., Veres, G., Pár, G., Pár, A., Szalay, F., Lakatos, P., Antal-Szalmás, P., Papp, M.: Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.
Sci. Rep. 8 (1), 1-11, 2018.

Satishchandran, A., Ambade, A., Rao, S., Hsueh, Y., Iracheta-Vellve, A., Tornai, D., Lowe, P., Gyöngyösi, B., Li, J., Catalano, D., Zhong, L., Kodys, K., Xie, J., Bala, S., Gao, G., Szabó, G.: MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
Gastroenterology. 154 (1), 238-252, 2018.

Tornai, T., Pályu, E., Vitális, Z., Tornai, I., Tornai, D., Antal-Szalmás, P., Norman, G., Shums, Z., Veres, G., Dezsőfi, A., Pár, G., Pár, A., Orosz, P., Szalay, F., Lakatos, P., Papp, M.: Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.
World J. Gastroenterol. 23 (29), 5412-5421, 2017.

Földi, I., Tornai, T., Tornai, D., Sipeki, N., Vitális, Z., Tornai, I., Dinya, T., Antal-Szalmás, P., Papp, M.: Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections.
Liver Int. 37 (7), 1023-1031, 2017.

Tornai, T., Vitális, Z., Sipeki, N., Dinya, T., Tornai, D., Antal-Szalmás, P., Karányi, Z., Tornai, I., Papp, M.: Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
Liver Int. 36 (11), 1628-1638, 2016.

Papp, M., Tornai, T., Vitális, Z., Tornai, I., Tornai, D., Dinya, T., Sümegi, A., Antal-Szalmás, P.: Presepsin teardown: pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
World J. Gastroenterol. 22 (41), 1-14, 2016.

Antal-Szalmás, P., Földi, I., Tornai, D., Tornai, T., Vitális, Z., Tornai, I., Dinya, T., Papp, M.: Serum levels of lectin complement pathway molecules do not determine the risk of bacterial infections in patients with cirrhosis.
Clin. Chem. Lab. Med. 54 (10), 162, 2016.

Papp, M., Tornai, T., Kovács, G., Vitális, Z., Tornai, I., Fechner, K., Roggenbuck, D., Tornai, D., Norman, G., Shums, Z., Veres, G., Orosz, P., Lomaby, B., Gervain, J., Pár, G., Pár, A., Lakatos, P., Szalay, F., Antal-Szalmás, P.: Target-specific anti-pancreatic antibodies are frequent in patients with primary sclerosing cholangitis and associated with poor disease outcome.
In: Gut-Liver Interactions: From IBD to NASH - March 11-12, 2016, Congress Innsbruck : Abstracts, Poster Abstracts. Eds.: H. Tilg, A. Kaser, M. P. Manns, G. Szabo, M. Trauner, Karger, Basel, 1-2, 2016.

Papp, M., Tornai, T., Tornai, D., Vitális, Z., Tornai, I., Antal-Szalmás, P.: Presepsin as a new biomarker for old expectations in the diagnosis and prognosis of bacterial infection in cirrhosis.
Hepatology. 62 (S1), 1227A, 2015.

Tornai, T., Tornai, D., Sipeki, N., Földi, I., Dinya, T., Vitális, Z., Antal-Szalmás, P., Tornai, I., Papp, M.: Soluble CD163 (SCD163) is a marker of infection in patients with cirrhosis and acute decompensation and an independent predictor of the short-term mortality.
J. Hepatol. 62 (Supplement), S368, 2015.

Tornai, T., Tornai, D., Dinya, T., Vitális, Z., Lakatos, P., Antal-Szalmás, P., Tornai, I., Papp, M.: Soluble CD163 (sCD163) is a marker of infection in patients with cirrhosis and acute decompensation and an independent predictor of the short-term mortality.
Gastroenterology. 148 (4_Suppl_1), S-1009, 2015.

Vitális, Z., Altorjay, I., Tornai, I., Palatka, K., Kacska, S., Pályu, E., Tornai, D., Udvardy, M., Hársfalvi, J., Dinya, T., Veres, G., Lakatos, P., Papp, M.: Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis.
Hum. Immunol. 72 (4), 348-354, 2011.